欢迎来到天天文库
浏览记录
ID:45340163
大小:17.15 KB
页数:8页
时间:2019-11-12
《利福喷丁与利福平治疗初治涂阳肺结核的疗效观察》由会员上传分享,免费在线阅读,更多相关内容在教育资源-天天文库。
1、利福喷丁与利福平治疗初治涂阳肺结核的疗效观察[摘要]目的探讨对于初治涂阳肺结核患者,采取利福平与利福喷丁治疗的疗效及安全性差异。方法方便选取该院接收的初治涂阳肺结核患者92例,接诊时间为2016年5月—2017年5月期间,随机分为对照组(n=46,予以RHZE治疗方案)与观察组(n=46,予以LHZE治疗方案),观察临床治疗疗效、痰转阴率、空洞改善率、不良反应发生情况。结果观察组在治疗的第3、第6个月的痰转阴率分别为86.9%、95.7%,较对照组显著要高(χ2=12.93、15.86,P<0.05);同时相较于对照组,观
2、察组患者总有效率95.7%显著要高(χ2=11.12,P<0.05),同时相较于对照组,观察组患者空洞改善率95.65%显著要高(χ2=7.256,P<0.05);此外,相较于对照组,观察组患者的肝细胞异常率、白细胞下降率、皮疹率及胃肠道反应率显著要低(P<0.05)。结论对于初治涂阳肺结核患者,采取利福喷丁治疗具有低毒、高效、长效等优点,具有推广价值。[关键词]利福平;初治涂阳肺结核;利福喷丁[中图分类号]R521[文献标识码]A[文章编号]1674-0742(2018)07(a)-0117-03TherapeuticE
3、ffectofRifapentineandRifampicinintheTreatmentofNewlyDiagnosedSmear-positivePulmonaryTuberculosisFANGChu-kuiDepartmentofInfectiousDiseases,ShanweiPeople'sHospital,Shanwei,GuangdongProvince,516600China[Abstract]ObjectiveThispapertriestoinvestigatetheefficacyandsafet
4、yofrifampinandrifapentineinpatientswithnewlydiagnosedsmear-positivepulmonarytuberculosis.Methods92newlydiagnosedsmear-positivepulmonarytuberculosispatientsreceivedinthehospitalwereconvenientselectedfromMay2016toMay2017.Theywererandomlydividedintocontrolgroup(n=46,
5、RHZEtreatmentregimen)andobservationgroup(n=46,toLHZEtreatmentprogram)toobservetheclinicaltreatmentefficacy.ResultsIntheobservationgroup,thenevusturnoverratewas86.9%and95.7%atthe3rdand6thmonthoftreatmentrespectively,whichwassignificantlyhigherthanthatofthecontrolgr
6、oup(χ2=12.93,15.86,P<0.05);Thetotaleffectiverateintheobservationgroupwas95.7%(χ2=11.12,P<0.05).Comparedwiththecontrolgroup,thevoidimprovementratewas95.65%intheobservationgroupwassignificantlyhigher(χ2=7.256,P<0.05).Inaddition,comparedwiththecontrolgroup,thehepatoc
7、yteabnormalityrate,leukocytedeclinerate,skinrashrate,andgastrointestinalreactionrateintheobservationgroupweresignificantlylower(P<0.05).ConclusionForpatientswithnewlydiagnosedsmear-positivepulmonarytuberculosis,takingrifapentinetreatmenthastheadvantagesoflowtoxici
8、ty,highefficiencyandlong-termefficacy,andhasthepromotionvalue.[Keywords]Rifampicin;Initialtreatmentofsmear-positivetuberculosis;Rifapentine結核病是常见的慢性传染性疾
此文档下载收益归作者所有